Jefferies’ Post

SPAC Feed: PepperLime Health Acquisition in a regulatory filing said it continues to explore options other than liquidation. One option is a… - https://lnkd.in/eJiKveXV #SPACs #SPACNews #SPAC #IPO #markets #news #capitalmarkets #trends #goingpublic #finance #business

Bansk Group's Acquisition of PetIQ, Inc. - Bansk Group has agreed to acquire PetIQ, Inc. in a deal valued at approximately $1.5 billion. This all-cash transaction will see PetIQ stockholders receive $31.00 per share, representing a substantial 41% premium over the pre-announcement average stock price. - This acquisition is a significant event in the pet healthcare industry, with Bansk Group aiming to integrate PetIQ's extensive distribution network in pet medication and wellness into its consumer health products portfolio. Cord Christensen, CEO of PetIQ, highlighted the deal's attractiveness, noting the considerable premium for shareholders and the anticipated growth under Bansk’s ownership. - Bansk Group, renowned for its investments in consumer brands, recognizes PetIQ's established operations and comprehensive product lineup as valuable assets in the rapidly expanding pet health and wellness market. Chris Kelly, a senior partner at Bansk, praised the PetIQ team for developing a robust platform that simplifies pet care for consumers. - The transaction is slated to close in the fourth quarter of 2024, pending approval from PetIQ stockholders and regulatory clearances, including those required under the Hart-Scott-Rodino Antitrust Improvements Act. The deal's full funding, free from financing conditions, underscores the strong financial support and confidence in its successful completion. - Post-acquisition, PetIQ will transition to a privately held company while maintaining its current executive leadership to ensure continuity in management and operational strategy. Following the completion of the transaction, PetIQ’s stock will be delisted from the NASDAQ. - Legal advisement for the transaction was provided by Cooley LLP to PetIQ and Davis Polk & Wardwell LLP to Bansk Group, ensuring regulatory compliance and facilitating a smooth transaction process. #banskgroup #petechcare #petiq #acquisition #mergersandacquisitions #consumerhealth #investment #healthandwellness #legaladvisors #marketexpansion

Crowell & Moring’s Jeane A. Thomas and Alexis Gilman discuss the final merger guidelines released by the FTC and DOJ. Read more with a subscription to Modern Healthcare:

Crowell & Moring’s Jeane A. Thomas and Alexis Gilman discuss the final merger guidelines released by the FTC and DOJ. Read more with a subscription to Modern Healthcare:

Crowell & Moring’s Jeane A. Thomas and Alexis Gilman discuss the final merger guidelines released by the FTC and DOJ. Read more with a subscription to Modern Healthcare:

"Healthcare transactions, particularly those involving private equity, are facing an increasing mix of state and federal regulatory requirements. Mergers that would have drawn little scrutiny a few years ago will now require a multijurisdictional risk analysis upfront. Any state premerger filing that garners state enforcement interest could lead to a parallel — but separate — FTC or DOJ investigation. This risk is increased by the fact that smaller, nonreportable deals may now require premerger notification under new state laws. In the end, parties involved in strategic or multistate healthcare transactions should identify risks from both state and federal regulations during the deal formation process."

Crowell & Moring’s Jeane A. Thomas and Alexis Gilman discuss the final merger guidelines released by the FTC and DOJ. Read more with a subscription to Modern Healthcare:

Vista Equity Partners, an American private equity firm, agreed to acquire Model N, a provider of revenue optimization and compliance for pharmaceutical, medtech, and high-tech innovators, for $1.25bn. "We are pleased to have reached this agreement with Vista, which is the culmination of a robust sale process led by our Board of Directors with the assistance of our financial and legal advisors. As the Board considered the long-term path for Model N, we unanimously determined that the transaction with Vista represents the best opportunity to deliver compelling, certain, and immediate cash value to our stockholders and is in their best interest in light of the challenges faced by Model N as a standalone public company," Baljit Dail, Model N Chairman of the Board. Model N (led by Baljit Dail, Jason Blessing, and John Ederer) is advised by Jefferies and Fenwick & West. Vista Equity Partners (led by Nick Prickel) is advised by Kirkland & Ellis. #MergersAcquisitionsDivestitures #PrivateEquity #Software

California Settles $7.7M in Unclaimed Property with Healthcare Provider This California settlement brings new focus and risks to #unclaimedproperty compliance by #healthcare providers. In addition to #whistleblower lawsuits, #healthcare companies should carefully access #unclaimedproperty liabilities through #acquisitions, including the activity that triggers the dormancy for reporting #unclaimedproperty to the State of #California. Read more here: https://lnkd.in/gt4dyqqv

Planning for your M&A transaction is not just about planning for yourself, it’s also about providing for your patients. Whether you are a doctor, dentist or other healthcare professional who is considering a sale of your practice, or you are a private equity fund who is engaged in acquisitions of medical practices, there are some key considerations and concerns — from financial security, patient care, and fiduciary duties — that go beyond purchase price. All these and more are addressed in a PE acquisition, as we responsibly transition these important businesses. Is there a physician in your life who is thinking about the next step in their business journey? Share this post with them. We’re here to help. #healthcare #privateequity #mergersandacquisitions #ppm #physician